Visit the ACCC COVID-19 Resource Center & Listserv for Insights on Providing Optimal Patient Care During the Pandemic.
Home / Learn / Oncology Pharmacy / Resource Detail

Multidisciplinary Molecular Tumor Boards: Two Models

June 28, 2019

As identification of actionable biomarkers in cancers continues to grow, there is an increasing need to bring together multidisciplinary molecular tumor boards to support the wider integration of precision medicine. At Moffitt Cancer Care in Tampa, Florida, a pharmacist-led multidisciplinary molecular tumor board service reviews individual patient NGS panel results and recommends treatment options. At University of Kentucky University of Kentucky (UK), Markey Cancer Center, patients who pursue clinical trials are treated in the Precision Medicine Clinic in which the clinical pharmacist specialist plays are pivotal role. Learn more about these two molecular tumor board models, plus panelists weigh in on optimal use of next-generation sequencing (NGS).

Related Content